It is dangerous to ignore irritable bowel syndrome (IBS) and inflammatory bowel disease (IBD) as those who suffer from it are more likely to have other chronic health conditions such as cardiovascular disease, respiratory disease, cancer, arthritis, kidney disease and liver disease.
Many aspects of modern living such as high stress levels, too little sleep, eating processed and high-sugar foods, and taking antibiotics can all damage our gut microbiome. Numerous studies in the past two decades have demonstrated links between gut health and the brain, heart, immune system, mood, mental health, autoimmune diseases, endocrine disorders, skin conditions, hormone levels, ability to absorb nutrients, and even cancer.
IBS affects the lower GI area, which includes the small intestine, large intestine, and colon. Patients with IBS experience chronic diarrhoea, constipation, bloating and gassy.
IBD causes inflammation of the intestines. IBD is a term for a broad spectrum of diseases, but Crohn’s disease and ulcerative colitis are the most common. How severe the disease is depends on a combination of genetic abnormalities and the effects of any number of microbes on the immune system. The most common symptom is diarrhoea. Other symptoms include abdominal cramps, bloody stool, blocked bowels, fever, loss of body fluids and appetite, extreme weight loss, and anaemia.
How do you know when you are having just a stomach pain, or something more serious? Discover the truth with genetic testing.
Immune-mediated diseases co-occur in families, and individuals diagnosed with one disease have been shown to be at increased risk of developing additional disorders.
Genome-wide association studies have identified a genetic overlap between IBD and a number of immune-mediated diseases, including ankylosing spondylitis [AS], coeliac disease, psoriasis, systemic lupus erythematosus [SLE], rheumatoid arthritis [RA], and multiple sclerosis [MS].
Shared susceptibility points have also been described for some extra-intestinal manifestations [EIMs] in IBD, suggesting genetic background may also be a risk factor for EIM development.
Genes of Interest and Recommendations
TrueYou determines the variant profile of your 12 genes associated with gut irritability by testing the following for inflammatory bowel disease, Crohn’s disease, ulcerative colitis, type II diabetes mellitus and others: BSN, ATG16L1, PTGER4, ZNF300, ZNF365, NKX2-3, NOD2, PTPN2, IBD5, CDKAL1, HLA-DQB1, RSPH6A.
From the variant profile of your 12 genes, we can estimate your risk (mild, normal, or high) of gut irritability. Knowing that your genes encode a specific outcome, you can mitigate their effects with certain dietary changes (food choices, drink choices, and superior nutrition).
What you can take for supplementation:
Glutamine fuels intestinal cells and promotes gut health. Elken Spirulina is a natural whole food source which contains glutamine to improve digestive health and help balance out your system.
To help your gut stabilise, we recommend supplementing with: Elken ELFAHEX, which contains a patented ingredient, Mycelium Immuno Modulator Extract, or also known as MIME, that is extracted from mushrooms that has been researched to possess a high potency of polysaccharides in the form of ACETYLATED alpha-glucan. The patented cultivation process of Elken ELFAHEX ensures that the identity of the MIME cells remain the same for our body’s easy absorption.
Elken XENIJI contains 65 types of fruits and vegetables that have been broken down through a complete fermentation process over 1,200 days into a broad spectrum of bioactive micro-fine nutrients and enzyme catalyst. Elken XENIJI promotes efficient nutrient absorption to boost catalytic functions so as to enhance overall metabolism for efficient energy production and utilisation, and a healthy gut system.